by Carolyn Abrams | Feb 27, 2025 | commentary
Odyssey House President and CEO Dr. Peter Provet comments on how a recent article in the New York Times (“An Effective Treatment for Opioid Addiction Exists. Why Isn’t It Used More?”, February 16, 2025) on buprenorphine and stigma. The recent New York...
by Carolyn | Oct 20, 2024 | in the news, Letters to the Editor, marijuana
In today’s New York Times, Dr. Peter Provet, Odyssey House President & CEO, responds to a recent article about the growing use of marijuana after legalization. To the Editor: Re “Unexpected Problem in the Rise of Marijuana” (front page, Oct. 5): As we navigate the...
by Carolyn Abrams | Mar 3, 2023 | call to action, commentary, Dr. Peter Provet, in the news, Letters to the Editor, Opioid epidemic
In today’s New York Times, Dr. Peter Provet, Odyssey House President & CEO, responds to a recent article [“One Year Inside a Radical New Approach to America’s Overdose Crisis,” by Jeneen Interlandi (Opinion, Feb. 26)], and accompanying editorial [“America...
by Carolyn | Jan 23, 2020 | eldercare, in the news, Opioid epidemic, treatment
“I’m grateful people our age still get a chance to get it right. You know things the younger people don’t know because you’ve been through it.” ElderCare client Tamara talks about her opioid addiction and life in treatment at Odyssey...
by Carolyn | Jan 10, 2020 | commentary, Dr. Peter Provet, marijuana, teens, treatment
Below, Odyssey House President Dr. Peter Provet comments on an article in USA Today (“As marijuana-induced psychosis rises, parents say treatment for young people hard to find,” Jan. 6). A recent article illustrates a fallacy about marijuana: that it is fundamentally...
